CAC
GILD icon

Core Alternative Capital’s Gilead Sciences GILD Stock Holding History

Core Alternative Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$277K Buy
2,189
+319
+17% +$42K 0.08% 101
2026
Q1 		$261K Buy
1,870
+286
+18% +$40K 0.08% 103
2025
Q4 		$194K Buy
1,584
+1,278
+418% +$155K 0.05% 112
2025
Q3 		$34K Hold
306
– – 0.01% 144
2025
Q2 		$33.9K Hold
306
– – 0.01% 146
2025
Q1 		$34.3K Buy
306
+241
+371% +$24.9K 0.01% 146
2024
Q4 		$6K Hold
65
– – ﹤0.01% 223
2024
Q3 		$5.45K Hold
65
– – ﹤0.01% 226
2024
Q2 		$4.46K Hold
65
– – ﹤0.01% 231
2024
Q1 		$4.76K Sell
65
-564
-90% -$43.4K ﹤0.01% 223
2023
Q4 		$51K Sell
629
-867
-58% -$67.5K 0.01% 167
2023
Q3 		$112K Sell
1,496
-24
-2% -$1.85K 0.02% 137
2023
Q2 		$117K Buy
1,520
+243
+19% +$19.4K 0.02% 114
2023
Q1 		$106K Sell
1,277
-1,100
-46% -$91.1K 0.01% 111
2022
Q4 		$204K Buy
2,377
+73
+3% +$5.78K 0.03% 98
2022
Q3 		$142K Buy
2,304
+184
+9% +$11.6K 0.02% 100
2022
Q2 		$131K Buy
2,120
+170
+9% +$10.5K 0.03% 108
2022
Q1 		$116K Buy
1,950
+783
+67% +$50.1K 0.03% 109
2021
Q4 		$85K Buy
+1,167
New +$80.4K 0.02% 108

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Core Alternative Capital's GILD Position: Q2 2026 in Review

Core Alternative Capital increased its Gilead Sciences (GILD) stake by 17% in Q2 2026, buying an estimated $42K and bringing the position to 2,189 shares worth $277K. The position accounts for 0.08% of the portfolio, ranked #101.

Core Alternative Capital first reported a position in GILD in Q4 2021 and has held it in 19 quarters since. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Core Alternative Capital held 2,189 shares of Gilead Sciences worth $277K as of Q2 2026.
  • Core Alternative Capital bought 319 Gilead Sciences shares in Q2 2026, an estimated $42K.
  • Gilead Sciences made up 0.08% of Core Alternative Capital's portfolio in Q2 2026, its #101 holding.
  • Core Alternative Capital first reported a position in Gilead Sciences in Q4 2021 and has held it in 19 quarters since.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Core Alternative Capital's 13F filing for Q2 2026, filed 14 Aug 2026.